1.64 USD
↘ 0.63 (27.80%)AT CLOSE (11:59 AM EDT)
BioVie, Inc. Common Stock
BIVINASDAQ • USD
1.67
↗ 0.03 (1.65%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
1.67
↗ 0.03 (1.65%)
Market: CLOSED
BioVie, Inc. Common Stock (BIVI) trades at $1.63 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest BIVI is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jul 13, 2026.
Open?$2.23
High?$2.25
Low?$1.58
Prev. Close?$2.27
Volume?688.9K
Avg. Volume?171.8K
VWAP?$1.78
Rel. Volume?4.01x
Bid / Ask
Bid?$1.36 × 100
Ask?$1.66 × 100
Spread?$0.30
Midpoint?$1.51
Valuation & Ratios
Market Cap?17.1M
Shares Out?7.5M
Float?7.1M
Float %?94.3%
P/E Ratio?N/A
P/B Ratio?1.10
EPS?-$2.65
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
Employees
13
Market Cap
17.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-01-14
Address
680 W NYE LANE
CARSON CITY, NV 89703
Phone: 775-888-3162
CARSON CITY, NV 89703
Phone: 775-888-3162
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-26.92Distress
Confidence?41%Low
Short InterestElevated
Short % of Float?6.31%Elevated
Short Interest?449.0K
Days to Cover?2.0
Free Float7.1M
Avg Daily Volume223.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?9.97Strong
Quick Ratio?9.97Strong
Cash Ratio?7.73Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.10CHEAP▾
Peers100
S&P95
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-127.9%WEAK▾
S&P3
ROA?-114.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$4.0M
Fundamentals ratios updated end of day